HeartSciences (HSCS) Other Non Operating Income (2021 - 2026)
HeartSciences (HSCS) posted quarterly Other Non Operating Income of $13811.0 for Q2 2026, up 99.55% year-on-year from $6921.0 in Q2 2025, and up 537.04% on a QoQ basis from $2168.0 in Q4 2025.
HeartSciences (HSCS) Other Non Operating Income (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Other Non Operating Income for 6 consecutive years, with $13811.0 the latest figure, recorded in Q2 2026.
- Quarterly Other Non Operating Income rose 99.55% year-over-year to $13811.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $25713.0 (down 70.71% YoY) and the FY2026 annual result came in at $24033.0, down 72.63% from the prior year.
- Other Non Operating Income rose to $13811.0 in Q2 2026 per HSCS's latest filing, from $2168.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for HSCS reached as high as $54563.0 in Q2 2024 and fell as low as $3.0 in Q4 2023.
- A 5-year average of $10929.0 and a median of $2168.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 99.84% — and 2024, when it jumped 657000.0%.
- Year by year, Other Non Operating Income stood at $1199.0 in 2022, then plunged by 99.75% to $3.0 in 2023, then soared by 657000.0% to $19713.0 in 2024, then slumped by 89.0% to $2168.0 in 2025, then soared by 537.04% to $13811.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $13811.0, $2168.0, and $2813.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 13,811.00 |
| Oct 31, 2025 | 2,168.00 |
| Jul 31, 2025 | 2,813.00 |
| Apr 30, 2025 | 6,921.00 |
| Jan 31, 2025 | 14,657.00 |
| Oct 31, 2024 | 19,713.00 |
| Jul 31, 2024 | 46,504.00 |
| Apr 30, 2024 | 54,563.00 |
| Jan 31, 2024 | 16.00 |
| Oct 31, 2023 | 3.00 |
| Jul 31, 2023 | 60.00 |
| Apr 30, 2023 | 255.00 |
| Oct 31, 2022 | 1,199.00 |
| Jul 31, 2022 | 401.00 |
| Jan 31, 2022 | 851.00 |
| Jul 31, 2021 | 250,200.00 |